About Us

Focus on Healthcare & Biotechnology Investor Relations

Stern IR is the premier investor relations firm focusing on the entrepreneurial healthcare and biotechnology industries.

We have comprehensive, up-to-the-minute knowledge of the technical, regulatory and financial aspects of this very dynamic industry. We closely monitor industry trends to provide a comprehensive, data-driven approach to investor relations counsel.

We keep up to date on the frequent changes in the financial markets and the healthcare and biotechnology industries, and harness that knowledge to create personalized communications strategies. In addition, our clients’ needs change also: Stern IR recognizes the importance of routinely re-evaluating each client's IR program to address evolving corporate needs and the macro environment, in order to ensure maximum impact from the IR program.

We have longstanding and personal relationships with our clients and tailor each IR program to each client's specific needs and goals. We are committed to superior client service and are dedicated to providing senior level attention, strategic counsel and critical, disciplined tactical support.

Access: Key Relationships with the Healthcare and
Biotechnology Investment Community

As specialists in healthcare and biotechnology, we have cultivated valuable relationships within the investment community and know how to direct companies on who to meet, where to be, and when. We facilitate introductions and communications with crucial contacts on Wall Street and help our clients develop and improve existing relationships.

In the biotechnology sector, investor conferences and industry events are an important part of a successful IR program. We leverage our relationships in the industry to target the highest quality events for each client and to help obtain the most value from each event. Through a combination of meetings and roadshows, we familiarize the financial community with our clients and their unique prospects.


Focus on Best Investor Relations Practices

While each client has its own set of specific goals and tactics, we believe that high-quality companies should operate their investor relations programs according to current best industry practice. By coupling our deep experience with a reliance on data, we are able to offer our clients comprehensive guidance.

We work with our clients to communicate news and information to research analysts and investors regularly and consistently, with special attention to timing, position, accuracy, and fair disclosure practices. In addition, we provide appropriate guidance to clients to ensure they maintain the respect and trust that is vital to a company's reputation on Wall Street.

The Team

Our exceptional team of investor relations professionals offers a proven track record of delivering results for 20 years. Years of experience and superior client service allow us to provide sophisticated and critical direction, unique insights and a total perspective to meet clients' needs.

+ more - less

Lilian Stern has been a senior investor relations counselor in the biotechnology industry for over 20 years, representing more than 300 companies ranging from start-ups to large-cap public companies, in a broad range of development stages and therapeutic areas. As Principal of Stern IR, she works closely with all client teams, providing skilled and knowledgeable IR counsel. Lilian previously worked as a biotechnology sell-side analyst at Donaldson, Lufkin & Jenrette/Credit Suisse First Boston and was also Vice President of Biotechnology at AgriCapital Corporation. She holds an A.B. in Molecular Biology with distinction from Cornell University and a J.D. with honors from Harvard Law School.

Lilian is a member of National Investor Relations Institute (NIRI) as well as the New York Biotechnology Association (NYBA). Lilian established the Stern IR Foundation in 2008 to make contributions and otherwise support charities related to autism and other human health issues, as well as organizations that support cultural, educational and religious institutions. She sits on the board of Springboard Enterprises, the premier platform where entrepreneurs, investors, and industry experts meet to build great women-led businesses. Lilian is an omnivorous reader, enjoys crossword puzzles and is an avid Schubert fan.

+ more - less

Sarah McCabe is a Senior Vice President at Stern IR and has been with the firm since 2004. For over a decade, she has executed comprehensive and strategic IR programs for her private and public clients. She has worked alongside many client companies through their IPO process and assisted with implementing standard best practices for public company procedures and communications. Sarah has extensive experience with messaging and planning for drug approvals and launches, clinical trial results, corporate re-positioning, M&A and other related events. Sarah's previous work experience includes PR and event planning. She holds a Bachelor of Arts in Psychology from the University of Pennsylvania. Sarah enjoys spending time with her two boys, summers at the beach in East Hampton, riding her Peloton bike and eating at her favorite Philly restaurants.

+ more - less

Will O’Connor is an Associate at Stern IR, which he joined in 2014. He leads and supports both public and private client accounts, developing and executing wide-ranging investor relations programs that include strategic messaging and corporate presentation review, perception studies, and tactical coordination around conferences, R&D days and other special events. He holds a Bachelor of Arts in Government & Law from Lafayette College. Will enjoys traveling, reading the NY Times and spending time at the New Jersey shore.

+ more - less

Julie Seidel is a Director at Stern IR and joined the firm in 2015. She works with both public and private clients, assisting with their IR programs through tactical investor outreach and targeting, as well as the development of their broader strategic IR activity plans. Prior to joining Stern IR, Julie held intern positions focused on food- and nutrition-related public relations, as well as health and medical projects at The Hospital for Special Surgery and New York Presbyterian-Weill Cornell Medical Center. Julie attended Barnard College, where she graduated with a Bachelor of Arts in Psychology. In her free time, she enjoys cooking and re-watching Something’s Gotta Give.

+ more - less

Stephanie joined Stern IR in 2004 and is a Senior Vice President at the firm. She has worked with companies in a variety of therapeutic areas and development stages. She has experience working with a number of private companies, establishing IR programs and laying the groundwork for successful venture financing rounds and IPOs, and guiding many of these companies as they establish effective public company practices post-IPO. She has also worked with a wide range of public companies, implementing major communications and IR initiatives including analyst days, data announcements and scientific presentations, regulatory updates, new product launches and M&A transactions. Her previous work experience includes positions in brand marketing and educational publishing. She graduated from Cornell University with a Bachelor of Arts degree in English. Stephanie enjoys exploring NYC with her husband, son and spunky Labradoodle, being a foodie, cycling and travel.

+ more - less

Hannah Deresiewicz is a Senior Associate at Stern IR and joined the firm in mid-2013. She works with international public and private clients, developing and implementing comprehensive investor relations programs that encompass strategic messaging and presentation review, in-depth research projects and perception studies, and tactical coordination around conferences, R&D days and special events. Hannah has experience advising private companies on the execution of crossover deals, acquisitions and IPOs, and assisting public companies with the drafting of communications around earnings announcements and partnerships. She graduated summa cum laude from Columbia University with a Bachelor of Arts in political science and sociology. Hannah is a life-long New York Yankees fan, but will forever be a devoted Bostonian!

+ more - less

Christina Tartaglia is an Associate at Stern IR and joined the firm in 2015. She works with both public and private clients, developing and implementing comprehensive investor relations programs that encompass strategic messaging and presentation review, in-depth research projects and perception studies, and tactical coordination around roadshows, conferences, R&D days and special events. Prior to joining Stern IR, Christina worked as a researcher at Amarin Pharma, New York Medical College and Brigham and Women’s Hospital. She graduated from Harvard University with a Bachelor of Arts in Molecular and Cellular Biology with Honors, and a minor in Health Care Policy. Christina also received a Business Certificate from Columbia University.